We are live on ! Find out more
Loomis, Sayles & Company

Loomis, Sayles & Company Portfolio holdings

AUM $74.3B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
+13.58%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$62B
AUM Growth
+$4.39B
Cap. Flow
-$1.97B
Cap. Flow %
-3.18%
Top 10 Hldgs %
43.7%
Holding
1,103
New
130
Increased
284
Reduced
500
Closed
130

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$218M
2
PH icon
Parker-Hannifin
PH
+$155M
3
ILMN icon
Illumina
ILMN
+$80.7M
4
DIS icon
Walt Disney
DIS
+$74.2M
5
AZEK
The AZEK Co
AZEK
+$56.4M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$819M
2
META icon
Meta Platforms (Facebook)
META
+$338M
3
MSFT icon
Microsoft
MSFT
+$131M
4
AMZN icon
Amazon
AMZN
+$106M
5
CRM icon
Salesforce
CRM
+$93.2M

Sector Composition

Rank Sector Weight
1 Technology 27.29%
2 Communication Services 16.35%
3 Consumer Discretionary 16.22%
4 Healthcare 12.62%
5 Financials 10.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADBE icon
51
Adobe
ADBE
$105B
$154M 0.25%
315,325
-12,913
-4% -$5.2M
GS icon
52
Goldman Sachs
GS
$303B
$154M 0.25%
476,137
-17,911
-4% -$5.89M
TSM icon
53
TSMC
TSM
$2.18T
$145M 0.23%
1,434,133
-53,506
-4% -$4.98M
FANG icon
54
Diamondback Energy
FANG
$52.7B
$141M 0.23%
1,074,166
+220,675
+26% +$29.5M
TXN icon
55
Texas Instruments
TXN
$261B
$127M 0.21%
708,103
-26,659
-4% -$4.59M
MELI icon
56
Mercado Libre
MELI
$92.3B
$124M 0.2%
104,695
-2,591
-2% -$3.26M
KBR icon
57
KBR
KBR
$4.8B
$123M 0.2%
1,885,869
-134,158
-7% -$8M
ALNY icon
58
Alnylam Pharmaceuticals
ALNY
$29.3B
$123M 0.2%
645,143
-13,083
-2% -$2.59M
NKE icon
59
Nike
NKE
$61.9B
$120M 0.19%
1,090,926
+31,153
+3% +$3.64M
P
60
Everpure Inc
P
$29.9B
$115M 0.19%
3,121,685
-443,681
-12% -$12.6M
CNMD icon
61
CONMED
CNMD
$1.47B
$108M 0.17%
797,710
-5,353
-0.7% -$653K
OPCH icon
62
Option Care Health
OPCH
$3.56B
$103M 0.17%
3,155,736
+147,956
+5% +$4.46M
TXRH icon
63
Texas Roadhouse
TXRH
$13.7B
$100M 0.16%
894,501
-17,751
-2% -$1.95M
HXL icon
64
Hexcel
HXL
$7.82B
$98.2M 0.16%
1,291,899
-26,667
-2% -$1.9M
KNSL icon
65
Kinsale Capital Group
KNSL
$8.51B
$96.7M 0.16%
258,428
-5,297
-2% -$1.76M
RMBS icon
66
Rambus
RMBS
$11B
$93.6M 0.15%
1,458,011
-537,161
-27% -$29.6M
WFRD icon
67
Weatherford International
WFRD
$6.22B
$93.5M 0.15%
1,407,175
+38,170
+3% +$2.35M
ZION icon
68
Zions Bancorporation
ZION
$10.3B
$93.1M 0.15%
3,464,395
+1,111,507
+47% +$30.8M
DOCS icon
69
Doximity
DOCS
$4.88B
$92.2M 0.15%
2,709,306
+109,938
+4% +$3.66M
AEIS icon
70
Advanced Energy
AEIS
$13B
$85.2M 0.14%
764,247
+7,813
+1% +$745K
SLAB icon
71
Silicon Laboratories
SLAB
$7.23B
$83.6M 0.13%
530,274
-9,335
-2% -$1.41M
INSP icon
72
Inspire Medical Systems
INSP
$1.74B
$81.7M 0.13%
251,793
-34,824
-12% -$9.95M
ACA icon
73
Arcosa
ACA
$7.11B
$81.5M 0.13%
1,075,624
+118,181
+12% +$7.95M
BAC.PRL icon
74
Bank of America Series L
BAC.PRL
$3.99B
$81.3M 0.13%
2,835,020
SITE icon
75
SiteOne Landscape Supply
SITE
$4.53B
$78M 0.13%
466,014
-9,033
-2% -$1.33M

Similar funds

Loomis, Sayles & Company's Q2 2023 Portfolio in Review

As of Q2 2023, Loomis, Sayles & Company held 1,103 positions worth $62B, up 7.6% from $57.6B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Loomis, Sayles & Company withdrew a net $1.97B in Q2 2023, closing 130 positions and reducing 500 holdings. Its most notable exit was Halozyme, an estimated $81.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Communication Services and Consumer Discretionary.

Against the trend, Loomis, Sayles & Company opened a new position in The AZEK Co worth $66.1M.

  • Loomis, Sayles & Company's largest Q2 2023 buy was The AZEK Co: 2,181,837 shares worth $66.1M.
  • Loomis, Sayles & Company added most to Tesla in Q2 2023, an estimated $218M increase.
  • Loomis, Sayles & Company's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $819M.
  • Loomis, Sayles & Company fully exited Halozyme in Q2 2023, selling an estimated $81.3M.
  • Loomis, Sayles & Company's ten largest holdings make up 44% of its $62B portfolio in Q2 2023.
  • Loomis, Sayles & Company opened 130 new positions and closed 130 in Q2 2023.
  • Loomis, Sayles & Company's portfolio value rose 7.6% quarter-over-quarter to $62B.

Based on Loomis, Sayles & Company's 13F filing for Q2 2023, filed 11 Aug 2023.